View in EDS HTML Full Text PDF Full Text

A Novel Triplet of Alisertib Plus Ibrutinib Plus Rituximab Is Active in Mantle Cell Lymphoma.

Saved in:
Bibliographic Details
Title: A Novel Triplet of Alisertib Plus Ibrutinib Plus Rituximab Is Active in Mantle Cell Lymphoma.
Authors: Subramani, Baskaran1 (AUTHOR) subramani@uthscsa.edu, Conway, Patrick J.1,2 (AUTHOR) patrick.conway@keiseruniversity.edu, Al-Khinji, Aisha1,3 (AUTHOR) aalkhinji@arizona.edu, Zhang, Kun1 (AUTHOR) zhangk@uthscsa.edu, Pandey, Ritu4 (AUTHOR) ritu@arizona.edu, Mahadevan, Daruka1,2,3,4 (AUTHOR) mahadevand@uthscsa.edu
Source: Cancers. Dec2024, Vol. 16 Issue 24, p4257. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers16244257